Arrow International catheter and arterial line kits recalled for contaminated anesthetic components
Arrow International catheter kits recalled for contaminated components
Arrow International included lidocaine, bupivacaine, and saline solution from a supplier with quality issues in multiple catheter and arterial line kits. The supplier's products showed signs of ineffectiveness and potential sterility problems, which could cause serious harm if compromised injectable products are used.
- Check the lot numbers on affected kits against the FDA recall list
- Do not use affected kits; quarantine them and contact your supplier
- Notify your healthcare facility's clinical engineering or materials management team immediately
Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2377-2026More Arrow recalls
- FDA-Device2026-06-24Arrow International hemodialysis kits recalled for contaminated anesthetic and saline solutions
- FDA-Device2026-06-24Arrow International PI CVC kits recalled for compromised sterility and drug ineffectiveness
- FDA-Device2026-06-24Arrow International PICC kits and stylets recalled for compromised sterility and drug ineffectiveness
- FDA-Device2026-06-24Arrow International PICC and JACC catheter kits recalled for contaminated anesthetic and saline components
- FDA-Device2026-06-24Arrow International Pacing PSI Kits recalled for potential drug ineffectiveness and sterility compromise
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief